RGEBX
Price
$72.22
Change
+$0.65 (+0.91%)
Updated
Dec 20 closing price
SOPVX
Price
$50.82
Change
+$0.53 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

RGEBX vs SOPVX

Header iconRGEBX vs SOPVX Comparison
Open Charts RGEBX vs SOPVXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$72.22
Change+$0.65 (+0.91%)
VolumeN/A
CapitalizationN/A
Allspring Opportunity A
Price$50.82
Change+$0.53 (+1.05%)
VolumeN/A
CapitalizationN/A
RGEBX vs SOPVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGEBX vs. SOPVX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and SOPVX is a Buy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 301B vs. SOPVX (1.94B). RGEBX pays higher dividends than SOPVX: RGEBX (0.16) vs SOPVX (0.00). RGEBX was incepted earlier than SOPVX: RGEBX (10 years) vs SOPVX (25 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. SOPVX (26.00). RGEBX has a lower initial minimum investment than SOPVX: RGEBX (250) vs SOPVX (1000). RGEBX annual gain was more profitable for investors over the last year : 19.08 vs. SOPVX (6.74). RGEBX return over 5 years is better than : 44.55 vs. SOPVX (16.35).
RGEBXSOPVXRGEBX / SOPVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years25 years-
Gain YTD18.6666.052308%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets301B1.94B15,531%
Annual Yield % from dividends0.160.00-
Returns for 1 year19.086.74283%
Returns for 3 years2.62-5.52-47%
Returns for 5 years44.5516.35273%
Returns for 10 years69.248.40825%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PL4.040.16
+4.12%
Planet Labs PBC
FIVN42.631.15
+2.77%
Five9
VEEV224.154.48
+2.04%
Veeva Systems
PRQR2.630.04
+1.54%
ProQR Therapeutics NV
BIVI1.90-0.18
-8.65%
BioVie Inc